Vor Biopharma announces 1-for-20 reverse stock split effective Sept 18, 2025

Vor Biopharma Inc.

Reverse stock split at 1-for-20 ratio effective 5:00 p.m. ET on September 18, 2025.
Pre-split shares ~136.8M; post-split ~6.84M (subject to fractional share cash-out).
Split-adjusted trading on Nasdaq begins September 19, 2025; new CUSIP 929033207.
Proportionate adjustments to exercise prices and shares under equity plans and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.